S. TOPUK Et Al. , "Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?," CURRENT PHARMACEUTICAL BIOTECHNOLOGY , vol.18, no.6, pp.516-522, 2017
TOPUK, S. Et Al. 2017. Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?. CURRENT PHARMACEUTICAL BIOTECHNOLOGY , vol.18, no.6 , 516-522.
TOPUK, S., Akyuva, Y., Karaaslan, N., Mutlu, C. A., Yilmaz, I., Isyar, M., ... Sirin, D. Y.(2017). Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?. CURRENT PHARMACEUTICAL BIOTECHNOLOGY , vol.18, no.6, 516-522.
TOPUK, SAVAŞ Et Al. "Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?," CURRENT PHARMACEUTICAL BIOTECHNOLOGY , vol.18, no.6, 516-522, 2017
TOPUK, SAVAŞ Et Al. "Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?." CURRENT PHARMACEUTICAL BIOTECHNOLOGY , vol.18, no.6, pp.516-522, 2017
TOPUK, S. Et Al. (2017) . "Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?." CURRENT PHARMACEUTICAL BIOTECHNOLOGY , vol.18, no.6, pp.516-522.
@article{article, author={SAVAŞ TOPUK Et Al. }, title={Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?}, journal={CURRENT PHARMACEUTICAL BIOTECHNOLOGY}, year=2017, pages={516-522} }